SIBP-02

· Shanghai Institute Of Biological Products

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SIBP-02, covering 2023-12-27 to 2023-12-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing SIBP-02 and Rituximab Combination With CHOP in Previously Untreated Subjects With CD20+ DLBCL [Phase 3]

See pricing